FILINGS
PFE 0000078003 | |||
---|---|---|---|
Filing Date | Form Type | Description | Document |
2023-04-28 | 4 | View Document | |
2023-04-28 | 4 | View Document | |
2023-04-28 | 4 | View Document | |
2023-04-28 | 4 | View Document | |
2023-04-28 | 4 | View Document | |
2023-04-17 | 4 | View Document | |
2023-04-17 | 4 | View Document | |
2023-04-17 | 4 | View Document | |
2023-04-14 | 4 | View Document | |
2023-04-14 | 4 | View Document | |
2023-04-14 | 4 | View Document | |
2023-04-12 | PX14A6G | View Document | |
2023-04-10 | DEFA14A | DEFA14A MEDIA | View Document |
2023-04-10 | DEFA14A | DEFA14A EMAIL | View Document |
2023-04-04 | PX14A6G | View Document | |
2023-04-04 | 4 | View Document | |
2023-04-04 | 4 | View Document | |
2023-04-04 | 4 | View Document | |
2023-04-04 | 4 | View Document | |
2023-04-03 | 4 | View Document | |
2023-04-03 | 4 | View Document | |
2023-04-03 | 4 | View Document | |
2023-04-03 | 4 | View Document | |
2023-03-30 | 3 | PRIMARY DOCUMENT | View Document |
2023-03-30 | DEFA14A | DEFA14A | View Document |
2023-03-30 | SC 13G | SC 13G ZURA BIO LIMITED | View Document |
2023-03-27 | SC 13D/A | SC 13D/A LONGBOARD PHARMACEUTICALS | View Document |
2023-03-23 | SC 13G/A | SC 13G A 2 PYXIS ONCOLOGY | View Document |
2023-03-23 | 4/A | PRIMARY DOCUMENT | View Document |
2023-03-22 | PX14A6G | PFIZER | View Document |
2023-03-21 | 4 | PRIMARY DOCUMENT | View Document |
2023-03-21 | 4 | View Document | |
2023-03-17 | 4 | View Document | |
2023-03-17 | 4 | View Document | |
2023-03-17 | 4 | View Document | |
2023-03-17 | ARS | ARS | View Document |
2023-03-16 | DEFA14A | DEFA14A NOTICE | View Document |
2023-03-16 | DEF 14A | DEF 14A | View Document |
2023-03-13 | 8-K | 8-K | View Document |
2023-02-28 | 4 | View Document | |
2023-02-28 | 4 | View Document | |
2023-02-28 | 4 | View Document | |
2023-02-28 | 4 | View Document | |
2023-02-28 | 4 | View Document | |
2023-02-28 | 4 | View Document | |
2023-02-28 | 4 | View Document | |
2023-02-28 | 4 | View Document | |
2023-02-28 | 4 | View Document | |
2023-02-27 | S-8 | PFIZER S-8 | View Document |
2023-02-24 | 4 | View Document | |
2023-02-24 | 4 | View Document | |
2023-02-24 | 4 | View Document | |
2023-02-24 | 4 | View Document | |
2023-02-24 | 4 | View Document | |
2023-02-24 | 4 | View Document | |
2023-02-24 | 4 | View Document | |
2023-02-24 | 4 | View Document | |
2023-02-24 | 4 | View Document | |
2023-02-24 | 4 | View Document | |
2023-02-24 | 4 | View Document | |
2023-02-24 | 4 | View Document | |
2023-02-24 | 4 | View Document | |
2023-02-23 | 10-K | 10-K | View Document |
2023-02-21 | 4 | View Document | |
2023-02-21 | 4 | View Document | |
2023-02-21 | 4 | View Document | |
2023-02-21 | 8-K | PFIZER 8-K FEB 21 2023 | View Document |
2023-02-13 | SC 13G/A | SC 13G/A PYXIS ONCOLOGY | View Document |
2023-02-13 | SC 13G | SC 13G AN2 THERAPEUTICS | View Document |
2023-02-09 | SC 13G/A | SCHEDULE 13G/A | View Document |
2023-02-07 | SC 13G/A | View Document | |
2023-02-03 | SC 13G/A | View Document | |
2023-02-01 | SC 13D/A | SC 13D/A HALEON PLC | View Document |
2023-01-31 | 8-K | 8-K | View Document |
2023-01-13 | 4 | View Document | |
2023-01-13 | 4 | View Document | |
2023-01-13 | 4 | View Document | |
2023-01-03 | 4 | View Document | |
2023-01-03 | 4 | View Document | |
2023-01-03 | 4 | View Document | |
2023-01-03 | 4 | View Document | |
2023-01-03 | 4 | View Document | |
2023-01-03 | 4 | View Document | |
2023-01-03 | 4 | View Document | |
2022-12-29 | SC 13G | SC 13G ORIC PHARMACEUTICALS | View Document |
2022-12-29 | 3 | PRIMARY DOCUMENT | View Document |
2022-12-16 | 4 | View Document | |
2022-12-16 | 4 | View Document | |
2022-12-16 | 4 | View Document | |
2022-12-16 | 4 | View Document | |
2022-12-13 | 8-K | PFIZER INC 8-K DECEMBER 9, 2022 | View Document |
2022-12-01 | 4 | View Document | |
2022-12-01 | 4 | View Document | |
2022-12-01 | 4 | View Document | |
2022-11-16 | 4 | View Document | |
2022-11-16 | 4 | View Document | |
2022-11-16 | 4 | View Document | |
2022-11-09 | 4 | View Document | |
2022-11-09 | 10-Q | 10-Q | View Document |
2022-11-01 | 4 | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.